Thank you, Mr. Speaker. Mr. Speaker, the review of the supplementary health program is in relation to all coverage for all types of thing, including the things the Member has described. That review is going to take some time. It will likely go into the next government and be something the next government is going to have to make some hard decisions on.

We did have a brief chat this morning, and I did confirm that to the Member. Since then, I haven't had an opportunity to talk to the department. Taking the Member's point that waiting that long could be problematic for many, many women, I have issued a directive to the Department of Health and Social Services to put in some interim measures to cover the treatment or the Mifegymiso on an interim basis until the conclusion of the supplementary health review.

This means that it will be a payment of last resort and that individuals must use either NIHB, Extended Health Benefits, Metis Health Benefits, and an insurance if they have it through their employer or indigent health benefits. Basically, low-income workers who don't have insurance will be covered once this directive goes into place. Thank you, Mr. Speaker.